Khanna, Lehar
Halfdanarson, Thorvardur R.
Sonbol, Mohamad B.
Eiring, Rachel
Prond, Teresa
Camilleri, Michael http://orcid.org/0000-0001-6472-7514
Article History
Received: 13 May 2021
Accepted: 31 May 2021
First Online: 7 August 2021
Declarations
:
: Thorvardur Halfdanarson—Research support: advanced Accelerator Applications (a Novartis company), Ipsen, Thermo Fisher Scientific; Consulting: advanced Accelerator Applications, Ipsen, Curium, Lexicon, ScioScientific, and ITM. The other authors do not have any conflicts of interest pertaining to this work.
: The study was conducted in a tertiary referral practice (Mayo Clinic), specifically in a clinical medical oncology clinic. Data were collected via the Advanced Cohort Explorer (ACE) application available at Mayo Clinic. ACE is a clinical data repository maintained by the Unified Data Platform.
: Patients had approved use of their medical records for research purposes.
: This retrospective review study was approved by the Mayo Clinic Institutional Review Board (IRB #20-006015) and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.